TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 17:43 | 11/15/24 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | 1 | 1 | S.d | -79 | 15.36 | 0 | -5 | 37 | D | |||||||||||||||
11/12/24 16:38 | 11/7/24 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S | -1,647 | 216.17 | 0 | -8 | 12 | M | ||||||||||||||||
11/8/24 12:48 | 11/6/24 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | S.dm | -880 | 67.29 | 0 | -13 | 119 | D | |||||||||||||||
11/5/24 16:25 | 11/1/24 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 2 | 6 | S.dm | -583 | 3.84 | 0 | -152 | 411 | D | |||||||||||||||
9/25/24 16:30 | 9/23/24 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | 1 | 2 | S.d | -1,127,000 | 49.00 | 0 | -23,000 | -100 | 0 | D | ||||||||||||||
8/29/24 17:02 | 8/27/24 | IQV | Iqvia Holdings Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S | -320 | 246.33 | 0 | -1 | 20 | D | |||||||||||||||
8/26/24 16:37 | 8/22/24 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S.dm | -3,175 | 390.73 | 0 | -8 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |